|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/095 | |
| A61K 39/13 | |||
| A61K 39/295 | |||
| A61K 39/00 | |||
| A61K 33/06 | |||
| A61K 33/08 | |||
| A61K 31/4375 | |||
| A61K 31/66 | |||
| A61K 39/39 | |||
| A61K 33/42 |
| (11) | Number of the document | 2680885 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12709382.1 |
| Date of filing the European patent application | 2012-03-02 | |
| (97) | Date of publication of the European application | 2014-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/050989 |
| Date | 2012-03-02 |
| (87) | Number | WO 2012/117377 |
| Date | 2012-09-07 |
| (30) | Number | Date | Country code |
| 201161448226 P | 2011-03-02 | US | |
| 201161565980 P | 2011-12-01 | US |
| (72) |
O`HAGAN, Derek, US
BAUDNER, Barbara, IT
SKIBINSKI, David A.G., SG
SINGH, Manmohan, US
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT |
| COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT |